Hyperlipidemia

Revision as of 15:34, 30 October 2011 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

For patient information click here Template:DiseaseDisorder infobox

WikiDoc Resources for Hyperlipidemia

Articles

Most recent articles on Hyperlipidemia

Most cited articles on Hyperlipidemia

Review articles on Hyperlipidemia

Articles on Hyperlipidemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperlipidemia

Images of Hyperlipidemia

Photos of Hyperlipidemia

Podcasts & MP3s on Hyperlipidemia

Videos on Hyperlipidemia

Evidence Based Medicine

Cochrane Collaboration on Hyperlipidemia

Bandolier on Hyperlipidemia

TRIP on Hyperlipidemia

Clinical Trials

Ongoing Trials on Hyperlipidemia at Clinical Trials.gov

Trial results on Hyperlipidemia

Clinical Trials on Hyperlipidemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperlipidemia

NICE Guidance on Hyperlipidemia

NHS PRODIGY Guidance

FDA on Hyperlipidemia

CDC on Hyperlipidemia

Books

Books on Hyperlipidemia

News

Hyperlipidemia in the news

Be alerted to news on Hyperlipidemia

News trends on Hyperlipidemia

Commentary

Blogs on Hyperlipidemia

Definitions

Definitions of Hyperlipidemia

Patient Resources / Community

Patient resources on Hyperlipidemia

Discussion groups on Hyperlipidemia

Patient Handouts on Hyperlipidemia

Directions to Hospitals Treating Hyperlipidemia

Risk calculators and risk factors for Hyperlipidemia

Healthcare Provider Resources

Symptoms of Hyperlipidemia

Causes & Risk Factors for Hyperlipidemia

Diagnostic studies for Hyperlipidemia

Treatment of Hyperlipidemia

Continuing Medical Education (CME)

CME Programs on Hyperlipidemia

International

Hyperlipidemia en Espanol

Hyperlipidemia en Francais

Business

Hyperlipidemia in the Marketplace

Patents on Hyperlipidemia

Experimental / Informatics

List of terms related to Hyperlipidemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Lipid and lipoprotein abnormalities are extremely common in the general population, and are regarded as a highly modifiable risk factor for cardiovascular disease due to the influence of cholesterol, one of the most clinically relevant lipid substances, on atherosclerosis. In addition, some forms may predispose to acute pancreatitis.

Classification

Risk factors

Hyperlipidemia screening

Target population | Screening tests | Screening frequency

Treatment

NCEP recommendations for children and adolescents with high-risk hyperlipidemia

Recommendations for drug therapy | Statins | Adjuvant therapies

References

External links

Hyperlipoproteinemia OMIM GPnotebook WebMD Others
Type I Online Mendelian Inheritance in Man (OMIM) 238600 Template:GPnotebook . MeritCare
Type IIa Online Mendelian Inheritance in Man (OMIM) 144400 Template:GPnotebook . Merck
Type IIb Template:GPnotebook .
Type III . Template:GPnotebook WebMD Yahoo
Type IV Online Mendelian Inheritance in Man (OMIM) 144600 Template:GPnotebook WebMD Yahoo
Type V Online Mendelian Inheritance in Man (OMIM) 144600 Template:GPnotebook . .

Template:Metabolic pathology Template:SIB

de:Hyperlipoproteinämie he:היפרליפידמיה sv:Hyperlipidemi


Template:WikiDoc Sources